For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Mitobridge, Inc.

USPTO Granted Patents = 20

EPO Patents = 6

Trademarks = 2

Forward Citations = 44

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Bharat Lagu (13 out of 25 patents)

Arthur F Kluge (12 out of 96 patents)

Michael Downes (8 out of 50 patents)

4. Taisuke Takahashi (8 out of 10 patents)

5. Ronald Mark Evans (8 out of 143 patents)

6. Ramesh Senaiar (6 out of 6 patents)

7. Sunil Kumar Panigrahi (6 out of 6 patents)

8. Nan Ji (5 out of 46 patents)

9. Masanori Miura (5 out of 20 patents)

10. Susanta Samajdar (5 out of 5 patents)

11. Michael A Patane (5 out of 52 patents)

12. Scott Trzaska (3 out of 10 patents)

13. Joseph Noel (3 out of 33 patents)

14. Thomas J Baiga (3 out of 11 patents)

15. John F W Keana (3 out of 28 patents)

20 patents: Sort by Forward Citations

1. 11993585 - Poly-ADP ribose polymerase (PARP) inhibitors (2024-05-28),

2. 11912681 - Crystalline and salt forms of PPAR agonist compounds (2024-02-27),

3. 11912679 - Aryl alkynamide derivatives (2024-02-27),

4. 11578052 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2023-02-14),

5. 11530192 - Crystalline and salt forms of PPAR agonist compounds (2022-12-20),

6. 11420934 - PPAR agonists (2022-08-23),

7. 11358954 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2022-06-14),

8. 11168080 - Dynamin-1-like protein inhibitors (2021-11-09),

9. 11034670 - Poly-ADP ribose polymerase (PARP) inhibitors (2021-06-15),

10. 10968172 - USP30 inhibitors (2021-04-06),

11. 10927094 - Crystalline and salt forms of PPAR agonist compounds (2021-02-23),

12. 10906885 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2021-02-02),

13. 10874641 - Methods of treating acute kidney injury (2020-12-29),

14. 10766888 - HMOX1 inducers (2020-09-08),

15. 10611790 - Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases (2020-04-07),

Mitobridge, Inc. is a biopharmaceutical company focused on developing innovative medicines to improve mitochondrial function and address diseases with high unmet medical need. Their mission is to advance a pipeline of novel therapeutics that can enhance the quality of life for patients suffering from various disorders associated with mitochondrial dysfunction.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

20 Patents

#115 in Cambridge, MA

#942 in Massachusetts

#15,890 in US

#30,364 in the World

Cambridge, MA, United States of America

Mitobridge, Inc.

Forward Citations = 44

39 inventors:

Bharat Lagu (13 out of 25 patents)

Arthur F Kluge (12 out of 96 patents)

Michael Downes (8 out of 50 patents)

4. Taisuke Takahashi (8 out of 10 patents)

5. Ronald Mark Evans (8 out of 143 patents)

Please report any incorrect information to support@idiyas.com

Loading…